Cardiovascular Medicine Fellowship Faculty

Robert E. Gerszten, MD, is Chief of Cardiovascular Medicine at the Cardiovascular Institute, Professor of Medicine at Harvard Medical School and a Senior Associate Member of the Broad Institute. His research focuses on the nexus of cardiac and metabolic diseases. This translational research program is a national leader in the use of metabolomics and proteomic technologies – and the integration of this information with human genetics – for the discovery of new biomarkers and pathways contributing to atherogenesis and its complications. The Gerszten team has identified novel biomarkers that single out individuals destined to develop diabetes and heart disease more than a decade before disease onset, with the goal of determining which of these patients might benefit from clinical interventions. Dr. Gerszten’s research is funded by the National Institutes of Health and the American Heart Association. He is an active clinician in the Coronary Care Unit. He is the recipient of the William Silen Lifetime Achievement in Mentoring Award from Harvard Medical School.

Peter J. Zimetbaum, MD, is the Richard and Susan Smith Professor of Cardiovascular Medicine at Harvard Medical School; Associate Chief and Clinical Director of Cardiology at BIDMC. He is a clinical electrophysiologist with a particular interest in the clinical management of atrial fibrillation, sudden death syndromes and complex device management. Dr. Zimetbaum directs the ECG and Arrhythmia Core Laboratory at the Baim Institute for Clinical Research and is the co-editor of Cardiology in Review. He authored the well-received textbook, Practical Clinical Electrophysiology.

Anne-Marie Anagnostopoulos, MD, FACC is the Director of Recruitment and Advancement of Women Fellows in Cardiology Training at BIDMC. She also serves as a member of the BIDMC Department of Medicine Advancement of Women committee. Dr. Anagnostopoulos is a general cardiologist whose interests include cardiovascular risk assessment of kidney and liver transplant candidates, cardiovascular disease in women, as well as echo interpretation.

Aarti H. Asnani, MD, is the Section Head of Cardio-Oncology at BIDMC and an Assistant Professor at Harvard Medical School. She is a principal investigator in the BIDMC CardioVascular Institute and an Associate Member of the BIDMC Cancer Research Institute. Dr. Asnani graduated from Duke University with a degree in chemistry and French. She completed clinical training in internal medicine and cardiology at Massachusetts General Hospital, followed by a postdoctoral fellowship in chemical biology. Dr. Asnani transitioned to BIDMC in 2017, where she leads a basic and translational research lab focused on mechanisms of cardiovascular toxicity associated with cancer therapies.

Mark Benson, MD, PhD, is Director of Preventive Cardiology at BIDMC and an Assistant Professor of Medicine at Harvard Medical School. His main clinical and research focus is on the application of emerging metabolomics, proteomics, and clinical phenotypic methods to identify new targets for metabolic and preventive atherosclerotic cardiovascular disease therapy. He works with a diverse group of collaborators and fellows to develop new ways to further study these methods in both laboratory and clinical settings.

Cliff Berger, MD, is an Instructor in Medicine at Harvard Medical School. He is Chief of the Division of Cardiology at Beth Israel Deaconess Hospital–Needham (BID–Needham) and oversees the hospital’s comprehensive community-based cardiology program. He also is a member of the Interventional Cardiology Division at BIDMC-Boston and Plymouth and also covers the Cardiology consult service at BIDMC-Boston. He trained at Beth Israel Deaconess Medical Center from 1988-1996 in Internal Medicine, Cardiology, and Interventional Cardiology and was also Chief Medical Resident in 1992.

Alfred E. Buxton, MD, is Ben-Haim Josephson Professor of Medicine at Harvard Medical School. He serves as a Director of the Clinical Electrophysiology Laboratory. He has authored or co-authored over 300 publications. He was Principal Investigator of the NIH-funded Multicenter Study of Non-Sustained Ventricular Tachycardia (MUSTT). His current research is focused on methods to predict risk of sudden cardiac death, appropriate role of implantable defibrillators for prevention of sudden cardiac death and mechanisms of ventricular tachycardia. He is the principal investigator of a prospective ongoing study evaluating mechanisms underlying conduction abnormalities in patients undergoing transcutaneous aortic valve replacement at Beth Israel Deaconess Medical Center.

Brett Carroll, MD, is Director of Vascular Medicine at BIDMC and Assistant Professor of Medicine at Harvard Medical School. He staffs the inpatient vascular medicine consult service and directs the Massive and Submassive Clot On-Call Team, BIDMC’s PE response team. His outpatient clinic focuses on aortic disease, peripheral vascular disease, venous thromboembolism, and lymphatic medicine, in addition to general cardiology. He also interprets vascular laboratory studies. His research interests include pulmonary embolism, lymphedema and management of aortic disease.

James D. Chang, MD, is Assistant Professor of Medicine at Harvard Medical School and a member of the CardioVascular Institute's Advanced Heart Failure Center program. He is involved in research activities pertaining to early detection and prevention of cancer therapeutics-associated cardiotoxicity and to the role of implantable hemodynamic monitoring devices in the management of advanced heart failure. In addition to his work in advanced heart failure, he is an active member of the echocardiography laboratory.

Donald Cutlip, MD, is Professor of Medicine at Harvard Medical School and a Senior Investigator at the Baim Institute for Clinical Research. His research interests include the study of clinical outcomes after percutaneous coronary intervention with special interest in patients with diabetes and stent thrombosis. Over the past 20 years he has been a leader in clinical trials of coronary intervention and has been responsible for the standardization of clinical endpoint definitions for these trials. He served as Director of the Cardiac Catheterization Laboratory at BIDMC from 2007-2017 and is currently a Vice Chair of the Department of Medicine, responsible for Clinical Care in the Community.

Andre d’Avila, MD, is the Director of the Cardiac Arrhythmia Service and The Harvard Thorndike Electrophysiology Institute. Dr. d’Avila is an internationally renowned clinician, teacher and researcher. He is a highly sought after lecturer and is committed to the advanced training of fellows in electrophysiology. His primary research focus is the mapping and ablation of complex atrial and ventricular arrhythmias. He and his colleagues in Brazil have pioneered the field of epicardial ablation and Dr. d’Avila was instrumental in bringing this technique to the United States. He has authored over 250 original scientific articles, 20 book chapters and a book on epicardial catheter ablation.

Loryn S. Feinberg, MD, is Assistant Professor of Medicine at Harvard Medical School, the director of the Women’s Cardiovascular Health Program and a clinical and non-invasive cardiologist.  She specializes in non-invasive testing, interpreting echocardiography and cardiac MRIs, attends in the CCU throughout the year and has an outpatient cardiology practice. Her clinical interests include the evaluation and treatment of women with cardiovascular disease and pregnant women with cardiac disease.

Ariane "CoCo" Fraiche, MD, is Instructor of Medicine at Harvard Medical School and a clinical and non-invasive cardiologist. Dr. Fraiche specializes in non-invasive testing with echocardiography as well as inpatient and outpatient consultative cardiology services in the community. Her clinical interests include preventive cardiology, valvular heart disease, coronary artery disease, and heart failure. She is a 2020-2021 Rabkin Fellow in Medical Education. Her research interests include medical education in cardiovascular disease as well as special topics in echocardiography and communication in cardiology.

A. Reshad Garan, MD, joins the faculty as the Director of Advanced Heart Failure. Having grown up in the Boston area, he now returns with his wife, Julie, and son, Zafer (4), from New York City and Columbia University where he completed his medical education, residency, fellowship, and advanced fellowship in Heart Failure, Mechanical Circulatory Support and Cardiac Transplantation. At Columbia, he served as the Director of the Acute Circulatory Support Program as well as the Associate Director of the CCU. His research interests include device support for advanced heart failure and cardiogenic shock.

Michael C. Gavin, MD, MPH, is Director of the CVI’s Cardiac Direct Access Unit, Director of Inpatient Cardiology at BIDMC and an Assistant Professor of Medicine at Harvard Medical School. Dr. Gavin's clinical practice focuses on valvular heart disease, coronary artery disease and preventive cardiology.

Eli Gelfand, MD, is an Assistant Professor of Medicine at Harvard Medical School and Section Chief of General Cardiology at BIDMC where he is responsible for cardiovascular outpatient operations. He is also active in developing the clinical applications of new and rapidly evolving diagnostic imaging modalities, such as three-dimensional (3D) and intracardiac echocardiography (ICE) and cardiovascular magnetic resonance (CMR) imaging with particular focus on imaging support of minimally-invasive therapies for valvular and congenital cardiac disease.

Ernest Gervino, ScD, is an Associate Professor of Medicine at Harvard Medical School and has been a member of the Cardiovascular Division since 1981. He is the Director of Clinical Physiology Laboratory at BIDMC and serves as the Director of Exercise Testing Core Lab at the Baim Institute of Clinical Research for both national and international research trials. His research interests include the stress testing as a primary endpoint, effects of exercise training on management of patients, diet and behavior modification on the reduction of risk for a second cardiac event.

C. Michael Gibson, MD, is a Professor of Medicine at Harvard Medical School, an interventional cardiologist, cardiovascular researcher & educator. He pioneered our understanding of the "open artery hypothesis" as well as our understanding of the importance of restoring flow downstream in the capillary bed in the "open microvasculature hypothesis." He is the CEO of the combined non-profit Baim and PERFUSE research institutes at Harvard Medical School. The institutes have led over 1,000 studies, published 3,000 manuscripts in the peer review literature, and have led 60 FDA submissions from their network of 7,000 sites worldwide. He is the Founder and Chairman of the Board of the non-profit WikiDoc Foundation, the world’s largest open source textbook of medicine. In 2014, 2018 and 2019 he was recognized as one of the most highly cited scientists in the world.

E. Wilson Grandin, MD, MPH, MEd, specializes in Advanced Heart Failure and Transplant Cardiology (AHFTC). He is the Director of the ECMO and Temporary Mechanical Circulatory Support (MCS) Program and the Site Director of the joint BIDMC-Tufts fellowship in AHFTC. He is engaged in clinical outcomes research focused on optimizing therapies for patients receiving durable or temporary MCS and heart transplant. He directs a simulation-based course on shock and MCS for trainees aimed at improving the management of patients with cardiogenic shock requiring circulatory support.

Charles Haffajee, MB, BChir, FRCP, is an Associate Professor of Medicine at Harvard Medical School and Director of Device Trials and Cardiac Electrophysiology Network Development. His primary interests are in pacing, defibrillation, congestive heart failure, cardiac arrhythmias, atrial fibrillation, syncope and ablation for cardiac arrhythmias.

Christopher Hoeger, MD, is an Instructor of Medicine at Havard Medical School and a member of the non-invasive cardiology staff at Beth Israel Deaconess Medical Center. His clinical interests include cardio-oncology, echocardiography, and cardiac MRI. He completed his residency training at the University of Michigan and cardiology fellowship at BIDMC. His research interests include the application of cardiac imaging to cardio-oncology.

Jennifer E. Ho, MD is an advanced heart failure cardiologist and serves as Director of Research in the Division of Cardiovascular Medicine at BIDMC. Her laboratory is focused on clinical and translational research to understand mechanisms underlying obesity-related cardiovascular disease including heart failure with preserved ejection fraction. She co-directs the BIDMC CardioVascular Institute’s T32 training grant, and is the recipient of multiple teaching and mentoring awards.

Kalon Ho, MD, MSc, is an Assistant Professor of Medicine and the Medical Director for Quality for BIDMC’s Division of Cardiovascular Medicine. He helps to coordinate BIDMC’s efforts to monitor the outcomes and improve the quality of cardiovascular care. His research interests include methodological issues in the design, management and analyses of clinical trials; assessment of outcomes of cardiovascular procedures, including use of large-scale, multicenter databases; and effective integration of decision support tools into clinical care. In addition to a clinical emphasis on invasive hemodynamics, he has been teaching clinical epidemiology at Harvard Medical School for more than 2 decades.

Patrick Hyland, MD is an Instructor of Medicine at Harvard Medical School and faculty member within the Section of Advanced Heart Failure, Cardiac Transplant, and Mechanical Circulatory Support. His interests include the use of left ventricular assist devices, management of cardiogenic shock, and cardiac transplantation. His clinical practice includes attending on the advanced heart failure step-down service and CCU, performing right heart catheterizations and endomyocardial biopsies, and seeing outpatients in the advanced heart failure clinic.

Peter M. Kang, MD, is an Associate Professor of Medicine at Harvard Medical School and Director of the Cardiac Physiology Core in BIDMC’s Cardiovascular Research Program. His laboratory is developing novel nanoparticle-based systems that are activated by hydrogen peroxide, for use in cardiovascular therapeutics and bio-imaging applications, and is currently investigating the molecular mechanism of cardiac dysfunction associated with vitamin D deficiency and examining the potential role of vitamin D therapy in the treatment of heart failure.

Joseph P. Kannam, MD, is an Assistant Professor of Medicine at Harvard Medical School and program director for the Cardiovascular Fellowship Program at Beth Israel Deaconess Medical Center. He is Chief of the Division of Cardiology at Beth Israel Deaconess Hospital–Needham (BID–Needham) and oversees the hospital’s comprehensive community-based cardiology program.

Dr. Clifford Kavinsky is Associate Professor at Harvard Medical School and Beth Israel Deaconess Medical Center.  Previously, He was Professor of Medicine and Pediatrics at Rush University Medical Center as well as the program director for the advanced fellowships in interventional cardiology and structural heart disease fellowship. He was Chief of the section of Structural and Interventional Cardiology, and the Director of the Rush Center for Congenital Structural Heart Disease. He is an expert on catheter-based therapies for heart and vascular disease, and is an internationally recognized leader in the use of novel treatments for adults with congenital and structural heart disease. His contributions to the field of structural heart disease have led him to be named Master in the Society of Cardiovascular Angiography and Interventions. Dr. Kavinsky has been a US News and World Report nationally ranked “Top Doctor” in Interventional Cardiology.

Dhruv Kazi, MD, MSc, MS, serves as the Director of the Cardiac Critical Care Unit and the Associate Director of the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology. He is a general cardiologist whose clinical focus is on the sustained delivery of high-quality, high-value cardiovascular care to critically ill patients. His research uses real-world data and mathematical modeling to examine the clinical and economic effects of new drugs, devices, and policies on population cardiovascular health. His work advances analytic methods in the fields of outcomes research and cost-effectiveness analysis, and facilitates their application to vulnerable populations in the US and overseas, with the overarching goal of increasing societal returns on healthcare expenditures.

Serge Korjian, MD, recently joined the division as a member of Interventional Cardiology. Dr. Korjian completed his residency and cardiovascular and interventional cardiology fellowships at BIDMC.

Daniel Kramer, MD, MPH, is Section Head of Electrophysiology and Digital Health at the Richard A. and Susan F. Smith Center for Outcomes Research and Assistant Professor of Medicine at Harvard Medical School, where he is also a faculty member at the Center for Bioethics. Dr. Kramer is a former Harvard Catalyst KL2 Scholar, Beeson Scholar, and Greenwall Faculty Scholar, and is currently supported by research grants from the NIA and NHLBI. His research group evaluates clinical outcomes, health policies, and bioethics questions arising from the use of medical devices.

Medical School: Stanford University
Residency: Brigham and Women's Hospital

Roger J. Laham, MD, is an Associate Professor of Medicine at Harvard Medical School and Co-Director of the Peripheral Vascular Disease Program. Dr. Laham is investigating novel angiogenesis and myogenesis strategies including stem cell and myotissue transplantations and novel imaging modalities including Multidetector CT (320) for coronary artery disease detection and PET/CT for vulnerable plaque imaging. In addition, he is developing and studying several cardiovascular devices including percutaneous valves, left atrial exclusion for atrial fibrillation, and myocardial restraint for congestive heart failure.

Brian Lilleness, MD, is a non-invasive Cardiologist with a focus on multi-modality imaging. He is an Instructor of Medicine at Harvard Medical School and the Director of Nuclear Cardiology at Beth Israel Deaconess Medical Center. He completed his residency and general cardiology fellowship at Boston Medical Center followed by an additional cardiovascular imaging fellowship at Brigham and Women’s Hospital. His time is spent between nuclear cardiology, cardiac MRI, and echocardiography as well as the inpatient and outpatient clinical settings. He has a strong interest in medical education and training others in the selection and interpretation of all cardiovascular imaging modalities.

Medical School: Tufts University
Residency: Beth Israel Deaconess Medical Center

Andrew Locke, MD, is an instructor of medicine at Harvard Medical School and a clinical cardiac electrophysiologist in the Harvard-Thorndike Electrophysiology Institute and Arrhythmia Service. He is the current medical director of the Left Atrial Appendage Occlusion Program at BIDMC. He has a clinical interest in the arrhythmia management of cardiac sarcoidosis patients serving as the co-founder of the Cardiac Sarcoidosis Center. Additionally, he is a faculty member of the VT Center at BIDMC. Dr. Locke directs a variety of peer-to-peer and fellow educational courses teaching advance ablation techniques.

Timothy Maher, MD is a cardiac electrophysiologist and Associate Director of VT Ablation at BIDMC, and he is an Instructor in Medicine at Harvard Medical School. Dr. Maher's academic focus is on complex scar-related VT ablation procedures where he is interested in novel functional substrate mapping techniques and advanced imaging integration to VT ablation procedures. He is the principal investigator of multiple ongoing pre-clinical and clinical EP catheter ablation studies. Dr. Maher's clinical practice includes comprehensive catheter ablation, device management, and medical management of cardiac arrhythmias.

Warren J. Manning, MD, is Professor of Medicine and Professor of Radiology at Harvard Medical School and the Section Chief of Noninvasive Cardiac Imaging and Testing in the CVI, where he also serves as Co-director of the Cardiac MR Center and Director of the Echocardiography Laboratory. A former president of the Society for Cardiovascular Magnetic Resonance, his ongoing research interests include cardiovascular applications of magnetic resonance (coronary MRI, valvular heart disease, subclinical atherosclerosis, atrial fibrosis in atrial fibrillation and pericarditis), utilization of echocardiography for prognosis in valvular heart disease and appropriateness of echocardiographic referrals.

Jason Matos, MD, is a non-invasive Cardiologist with a clinical focus in General Cardiology and Cardiac Imaging. His research interests include management of post-operative atrial fibrillation and imaging metrics associated with cardiovascular outcomes. He completed his residency and fellowship training at Beth Israel Deaconess Medical Center, and also served as Chief Medical Resident and Chief Cardiology Fellow. He also has a strong passion for medical education, serving as a Rabkin Fellow for Medical Education 2019-2020 and has re-designed the inpatient Cardiology and CCU curricula for medical residents.

Ian McCormick, MD, is an Instructor in Medicine at Harvard Medical School and enjoys working as a general cardiologist at Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess HealthCare - Chestnut Hill Square, and the Cardiac Direct Access Center at BIDMC. He also attends on the inpatient cardiology service and consult service at BIDMC.

Medical School: Harvard Medical School
Residency: Beth Israel Deaconess Medical Center
Michael Mi, MD, is a preventive cardiologist and Instructor in Medicine at Harvard Medical School. He is a graduate of Harvard Medical School and completed his internal medicine and cardiology training at Beth Israel Deaconess Medical Center. He sees patients in the Lipid and Cardiovascular Disease Prevention Clinic at BIDMC and has research and clinical interests in the roles that nutrition and exercise play in cardiovascular disease and longevity. His work thus far has focused on leveraging genomics, proteomics, and metabolomics to better understand the pathophysiology of cardiometabolic diseases.

Gregory F. Michaud, MD, is the Director of Cardiac Arrhythmia Services at BIDMC. He is a clinical electrophysiologist with a particular interest in catheter ablation of atrial fibrillation, supraventricular and ventricular tachycardia. Dr. Michaud is deeply involved in the education of cardiolgy fellows and early career cardiac electrophysiologists. He is a founding member of the American Board of Cardiovascular Medicine.

Murray A. Mittleman, MD, DrPH, is Program Director of the NIH-Funded T32 training program in Cardiovascular Research at BIDMC. He is a Professor of Epidemiology and Chair of the Master of Public Health Program at the Harvard T.H. Chan School of Public Health. He directs an active research program in Cardiovascular Epidemiology and Patient-Centered Outcomes Research based jointly at the Cardiovascular Division at BIDMC and the Department of Epidemiology at the Harvard School of Public Health. Recent research includes studies of racial and ethnic disparities among heart transplant recipients. His clinical practice in Preventive Cardiology is based at the Cardiovascular Health and Lipid Center at BIDMC.

Shweta R. Motiwala, MD, MPH, is an Instructor of Medicine at Harvard Medical School and a member of the CVI’s Advanced Heart Failure section. Her clinical practice focuses on the care of patients with heart failure, including those who require mechanical circulatory support devices and heart transplants. Her clinical and research interests include the development of chronic disease management programs, such as the use of implantable hemodynamic monitoring devices and other remote monitoring systems in heart failure, as well as studies focusing on serum biomarkers, quality of life, and patient-reported outcomes in heart failure.

Reza Nezafat, PhD, is a Professor of Medicine at Harvard Medical School and serves as the Scientific Director of the Cardiac MR Center. Dr. Nezafat completed his training at Johns Hopkins School of Medicine and National Institute of Health in Biomedical Engineering prior to joining Harvard Medical School. Dr. Nezafat’s research is to develop and apply new non-invasive methods in magnetic resonance imaging to guide therapy in cardiovascular disease.

Andrew Oseran MD MBA MSc is an advanced heart failure and transplant cardiologist and an investigator at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology. He completed his internal medicine residency, cardiology fellowship, and advanced heart failure and transplant fellowship at Massachusetts General Hospital. His research interests include questions related to the delivery of health care and understanding how domestic policy initiatives impact health care outcomes and cost.

Eric A Osborn, MD, PhD is the Director of the Interventional Cardiology Fellowship Program and an Assistant Professor at Harvard Medical School. He is also the Director of Intravascular Imaging at the Cardiovascular Imaging Core Laboratory. His clinical and research interests include complex percutaneous coronary intervention, intravascular imaging, coronary physiology, and translational investigation of novel interventional technologies. Dr. Osborn obtained his BS in Biomedical Engineering at Duke University, MS in Mechanical Engineering at the Massachusetts Institute of Technology, and MD-PhD from Harvard Medical School, followed by internal medicine residency, cardiology and interventional cardiology fellowships at BIDMC.

Panos Papageorgiou, MD, PhD, is an Assistant Professor of Medicine at Harvard Medical School. He is also a staff electrophysiologist. His clinical research has focused on atrial anisotropy and atrial pacing for atrial fibrillation prevention.

Duane S. Pinto, MD, MPH, is Associate Professor of Medicine and Chief of the Interventional Section. He also directs the Cardiovascular Imaging Core Laboratory which participates in investigating over 30 novel technologies include mitral and aortic valve replacement devices, thrombectomy devices, coronary and peripheral stents and drug eluting balloons as well as mechanical support devices. He performs coronary, peripheral vascular and structural procedures. His research interests evaluate procedural considerations and novel strategies to care for patients with shock states and complex coronary disease. He was a resident, chief resident, cardiology fellow and interventional fellow at BIDMC. He directed the general cardiology fellowship until 2014.

Jeffrey Popma, MD, is a Professor of Medicine at Harvard Medical School and the Director of Interventional Clinical Services at the BIDMC. Dr. Popma was a former President of the Society for Cardiovascular Angiography and Intervention and former Co-Chair of the American College of Cardiology Interventional Council. Dr. Popma also directs the BIDMC Angiographic Core Laboratory for numerous multicenter device studies for coronary and peripheral applications. Dr. Popma’s clinical interest include aortic and mitral transcatheter valve replacement and intervention, drug eluting coronary stents, and radial artery access procedures. Dr. Popma has published over 400 peer-reviewed manuscripts in the field of interventional and structural cardiology. Dr. Popma has recently moved to a senior position at Medtronic but will continue to see patients at BIDMC.

Marie-France Poulin, MD, is an interventional and Structural Cardiologist who serves as the Associate Director of the Structural Heart Clinical Services. She is also the Associate Program Director for the Interventional Cardiology Fellowship. Dr. Poulin spends her time between structural heart interventions, inpatient and outpatient structural consults, coronary interventions, cardiac intensive care unit, as well as maintaining a continuity clinic. Dr. Poulin was previously an interventional fellow here at BIDMC, after which she completed an advanced fellowship in Structural and Congenital Heart Disease Interventions at Rush University Medical Center in Chicago. She stayed on as faculty for a few years prior to coming back to BIDMC. Her clinical and research interests include percutaneous mitral therapies, TAVR, percutaneous PFO and ASD closure, intracardiac echocardiography, as well as LAA exclusion procedures.

Pablo Quintero Pinzon, MD is an Instructor of Medicine at Harvard Medical School and an advanced heart failure cardiologist. He is originally from Colombia. He is the Director of the Latinx Cardiovascular Clinic which delivers culturally sensitive cardiovascular care for Spanish speaking patients. He also serves as the Director of Under-represented Minority Trainee Affairs for the Department of Medicine. After joining BIDMC as faculty, he established a Heart Failure bio-repository in order to facilitate translational research efforts within the division. He also created a multidisciplinary amyloid clinic.

Anne Riley, MD, is an Instructor of Medicine at Harvard Medical School and joined the Cardiovascular Division at BIDMC and BID-Needham in 2011. She is a clinical cardiologist who sees general cardiology patients and performs non-invasive cardiac testing at BID-Needham. She attends on the inpatient cardiology service and the cardiology consult service at BIDMC.

Prashant Rao is a board-certified cardiologist and Instructor in Medicine at Harvard Medical School. Dr. Rao’s clinical practice is dedicated to the cardiovascular care of athletes, highly active individuals, and those with inherited cardiac conditions. Dr. Rao is also a member of the Cardiac Imaging Section, specializing in echocardiography and cardiopulmonary exercise testing. His translational research integrates human genetics, proteomics, and exercise physiology to enhance our understanding of how genetic and molecular factors influence cardiovascular health and fitness. In addition to his clinical and research roles, Dr. Rao currently serves as an Editorial Team member for the American College of Cardiology (acc.org) Sports and Exercise Cardiology section.

Jeremy Robbins, MD, is Associate Director of the Clinical Physiology Laboratory. His research interests are in the application of biochemical profiling to understand how exercise improves cardio metabolic health. His clinical interests include sports medicine, HFpEF, and applying advanced cardiopulmonary stress testing in the evaluation of patients with undifferentiated dyspnea. He attends in the Coronary Care Unit.

Marwa Sabe, MD, MPH, is Associate Director of Advanced Heart Failure and Director of the Left Ventricular Assist Device (LVAD) program. She is Assistant Professor of Medicine at Harvard Medical School. She works with patients with temporary and permanent support devices and heart transplantations at BIDMC and she spends part of each year working at Tufts Medical Center with advanced heart failure patients who have had placement of LVADs and transplants.

Eduardo Saad MD, Ph.D, serves as an Electrophysiologist in the Cardiac Arrhythmia Service at BIDMC. He received his medical training at the Federal University of Rio de Janeiro, Brazil, and served as the Chief Fellow of Cardiac Electrophysiology and Pacing at the Cleveland Clinic Foundation. Dr. Saad has extensive experience and academic involvement in catheter ablation for complex cardiac arrhythmias, device implantations, and left atrial appendage occlusions. He is an expert in using intracardiac echocardiography for performing procedures with zero fluoroscopy. Currently, he is the Chair of the Global Relations Committee and a Fellow of The Heart Rhythm Society, Fellow of the European Society of Cardiology, Board Member of the Latin American Heart Rhythm Society, and Director for International Relations for the Brazilian Society of Cardiac Arrhythmias. Dr. Saad has authored several original publications, editorials, guideline consensus statements and practice updates.

Jeffrey E. Saffitz, MD, PhD studies mechanisms of arrhythmias and myocardial injury in familial cardiomyopathies and sudden death syndromes. His current work is focused on innate immune signaling in the pathogenesis of arrhythmogenic cardiomyopathy and related syndromes.

Eric Secemsky, MD, MSc is the Director of Vascular Intervention and an interventional cardiologist at Beth Israel Deaconess Medical Center. He is also an investigator in the Richard A. and Susan Smith Center for Outcomes Research in Cardiology and an Associate Professor of Medicine at Harvard Medical School. He received his medical degree from Northwestern University and a Master’s of Science in Epidemiology from the Harvard School of Public Health. Dr. Secemsky completed his internal medicine training at the University of California, San Francisco, and Cardiovascular Medicine, Interventional Cardiology, and Vascular Diagnostics and Intervention training all at Massachusetts General Hospital. Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab, and the inpatient and outpatient vascular medicine services. Dr. Secemsky’s research program focuses on optimizing outcomes following coronary and peripheral vascular intervention, and includes comparative effectiveness research and clinical trials.

Keri Shafer, MD, a cardiologist focusing on adult congenital heart disease and pulmonary hypertension, has strengthened our ties with Boston Children’s Hospital and enhanced ACHD care. Dr. Shafer completed an internal medicine residency at Beth Israel Deaconess Medical Center in 2009 and subsequently completed an adult cardiovascular medicine fellowship in 2012 at UT Southwestern in Dallas. She returned to Boston in 2012 for an adult congenital heart disease and pulmonary hypertension fellowship at Boston Children’s Hospital and Brigham and Women’s Hospital before joining the Boston Adult Congenital Heart Group (BACH) in 2014. Her clinical/ research interests within ACHD include exercise physiology, echocardiography and medical education.

Changyu Shen, PhD, is a biostatistician whose research focuses on statistical methodology development in observational and randomized studies to infer treatment effect including efficacy and safety outcomes, with major applications in cardiovascular diseases. His primary research interests include development of new methods to study heterogeneity in treatment effect, where prediction models are developed to infer treatment effect for sub-populations; and control of false positives in clinical trials from empirical Bayes perspective.

Alexei Shvilkin, MD, is a Clinical Assistant Professor of Medicine at Harvard Medical School He completed residencies at Jacobi Medical Center in Medicine and at BIDMC in in Cardiology and a fellowship at BIDMC in Cardiac Electrophysiology. Dr. Shvilkin is an electrophysiologist at both BIDMC and South Shore Hospital.

Dr. Jordan Strom is Associate Professor of Medicine at Harvard Medical School, Director of the Echocardiography Laboratory, Director of Echocardiographic Research at Beth Israel Deaconess Medical Center in Boston, Massachusetts, and Section Head for Cardiovascular Imaging Research at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology. He is a practicing noninvasive cardiologist specializing in echocardiography and cardiovascular MRI. His research which has been funded by the NIH and American Heart Association involves evaluation of the relationship of cardiac structure and function to health outcomes and the optimal use and timing of cardiac imaging in practice. He was the inaugural American Society of Echocardiography (ASE) leadership academy member elected to the Board of Directors of the ASE, and serves on the American College of Cardiology (ACC) Imaging Council Leadership Committee, the Editorial Board of the Journal of the American Society of Echocardiography, the Board of Directors of the Joint Review Committee on Education in Diagnostic Medical Sonography, which accredits sonography training programs in the United States, the Board of Directors of the International Contrast Ultrasound Society, and is ACC commissioner to CAAHEP, the largest accreditor of allied health professions.

Usman Tahir, MD, MBI, is the Director of Cardiovascular Genetics at Beth Israel Deaconess Medical Center and an Instructor of Medicine at Harvard Medical School. Dr. Tahir’s clinical expertise is in the evaluation and management of inherited arrhythmia, cardiomyopathy and systemic disease. His research interests include the integration of bioinformatic approaches with detailed molecular phenotyping and application of novel omic technologies, in efforts to better understand cardiovascular disease processes. Dr. Tahir aims to translate these findings to clinical practice to provide patients with individualized medical care.

Hector Tamez, MD, MPH, is an Instructor in Medicine at Harvard Medical School, Interventional Cardiologist, Associate Clinical Director of the Cardiac Catheterization Laboratories, and the Co-Director of the Chronic Total Occlusion Percutaneous Coronary Intervention Program at the Beth Israel Deaconess Medical Center. He is an investigator in the Smith Center for Outcomes Research in Cardiology. His current research interest focus on outcomes after complex percutaneous coronary intervention (chronic total occlusion and in-stent restenosis).

Connie Tsao, MD, MPH, is member of the Non-Invasive Cardiac Imaging and Testing Section, specializing in echocardiography and cardiovascular magnetic resonance, and Assistant Professor of Medicine at Harvard Medical School. Cross-trained in epidemiology, she is also an investigator at the Framingham Heart Study and works with several NHLBI cohort studies. Her research interests are in non-invasive assessment of cardiovascular remodeling to understand the pathophysiology and prognosis of subclinical and clinical disease.

Patricia Tung, MD, completed her fellowship in Cardiology and Cardiac Electrophysiology at Beth Israel Deaconess Medical Center in Boston, MA. She is the Associate Director of the electrophysiology fellowship program. Her research interests involve the interaction between sleep apnea and arrhythmia. Dr. Tung is also committed to the advancement of women in EP. Dr. Tung performs ablation procedures for atrial fibrillation, atrial flutter and SVT, and implantation procedures for cardiac pacemakers and defibrillators.

Richard L. Verrier, PhD, FACC, is an Associate Professor of Medicine at Harvard Medical School and Director of Integrative Cardiac Electrophysiology Laboratory at BIDMC. His research focuses on neural control of heart rhythm with particular reference to atrial fibrillation and sudden cardiac death. He and his colleagues investigated cardioversion by pulmonary delivery of antiarrhythmic agents. They developed analytical means to detect ventricular repolarization abnormalities capable of noninvasively identifying the presence of clinically significant coronary artery stenosis and risk for malignant arrhythmia during routine exercise tolerance and pharmacologic stress testing. In collaboration with faculty members in Neurology, he has characterized a new entity, the "Epileptic Heart," which provides a framework for improved understanding of the factors responsible for premature cardiac death in patients with chronic epilepsy.

Rishi K. Wadhera, MD, MPP, MPhil is a cardiologist and the Associate Program Director of the Cardiovascular Medicine Fellowship. Dr. Wadhera received his MD from the Mayo Clinic School of Medicine and an MPhil in Public Health as a Gates Cambridge Scholar from the University of Cambridge. He competed his Internal Medicine Residency and Cardiovascular Medicine Fellowship at Brigham and Women’s Hospital. He also received an MPP at the Harvard Kennedy School of Government. Dr. Wadhera is a researcher at the Smith Center for Outcomes Research in Cardiology. His research focuses on health care access, quality and disparities, and understanding how health policy initiatives impact care and outcomes.

Jonathan W. Waks, MD, is a staff electrophysiologist. He directs the arrhythmia monitoring and ECG laboratories. Dr. Waks’ main research interests involve use of novel electrocardiographic and vectorcadiographic methods of assessing risk for ventricular arrhythmias and sudden cardiac death. He sees patients in the electrophysiology clinic on Shapiro 7, implants pacemakers and defibrillators, and performs ablations as well as electrophysiology studies.

Robert W. Yeh, MD, MSc, MBA, is Director of the Richard A. and Susan F. Smith Center for Outcomes Research, Section Chief of Interventional Cardiology at BIDMC, and the Katz-Silver Family Professor of Medicine at Harvard Medical School. His research is focused on the evaluation of cardiovascular interventions, devices and policies through the application of state-of-the-science causal inference methods to real-world datasets. His work is funded by the National Heart, Lung, and Blood Institute, the American College of Cardiology, and the US Food and Drug Administration. Clinically, Dr. Yeh specializes in complex coronary and chronic total occlusion intervention.

Meghan York, MD, is an Instructor of Medicine at Harvard Medical School and joined the Cardiovascular Institute in 2011. She attends on the general cardiology inpatient and consult services at BIDMC and maintains an active general cardiology practice at Beth Israel Deaconess Hospital–Needham. She serves as associate chief of cardiology of the Cardiovascular Institute at Beth Israel Deaconess Needham.